Skip to content

Innovex International INVX Stock Issued During Period Value Acquisitions

Stock Issued During Period Value Acquisitions at other companies

Nabors Industries logo
Nabors IndustriesNBR
$179.98M

Other financials

Income statement

See full
Revenue$239.0M-0.6%
Gross profit$84.5M+10.5%
Operating income-$21.8M-200%
Net income-$16.7M-213%
EPS (diluted)-$0.24-214%

Balance sheet

See full
Cash & equivalents$200.7M+195%
Total debt$100.4M+7.5%
Total equity$1.0B+5.4%
Total assets$1.3B+7.7%

Cash flow

See full
Operating cash flow$19.8M-36.2%
CapEx$223.0K-34.6%
Free cash flow$19.6M-36.2%

Valuation

See full
Market cap$1.76B+34.2%
Enterprise value$1.66B+23.7%
P/E33.9×+24.5×
P/S1.8×+0.1×

Profitability

See full
Gross margin31.9%-0.9pp
Operating margin9.1%+2.7pp
Net margin5.3%-12.9pp
FCF margin15%-9.6pp

Returns & leverage

See full
Return on equity5.2%-15.8pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.8×

Where this comes from

Reported directly by Innovex International in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueAcquisitions.

The official record: Innovex International’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innovex International's stock issued during period value acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innovex International's stock issued during period value acquisitions?
Innovex International (INVX) reported stock issued during period value acquisitions of $0 in Q4 2025.
How has Innovex International's stock issued during period value acquisitions changed year-over-year?
Innovex International's stock issued during period value acquisitions decreased by 100.0% year-over-year, from $31.22M to $0.
What does stock issued during period value acquisitions mean?
Represents the non-cash value of common stock issued as consideration for business acquisitions. This metric highlights the use of equity as a currency for inorganic growth, allowing the company to expand without depleting cash reserves. It provides insight into the dilution impact on existing shareholders and the company's strategy for funding expansion.